Apollon Wealth Management
PFE icon

Apollon Wealth Management’s Pfizer PFE Stock Holding History

Apollon Wealth Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$5.34M Buy
187,096
+18,262
+11% +$486K 0.06% 255
2026
Q2 		$4.07M Buy
168,834
+9,959
+6% +$261K 0.05% 313
2026
Q1 		$4.46M Buy
158,875
+6,652
+4% +$177K 0.07% 236
2025
Q4 		$3.79M Sell
152,223
-28,829
-16% -$727K 0.07% 247
2025
Q3 		$4.61M Sell
181,052
-6,304
-3% -$156K 0.08% 211
2025
Q2 		$4.54M Sell
187,356
-4,489
-2% -$105K 0.09% 198
2025
Q1 		$4.86M Sell
191,845
-10,183
-5% -$266K 0.11% 174
2024
Q4 		$5.36M Buy
202,028
+246
+0.1% +$6.67K 0.12% 145
2024
Q3 		$5.84M Sell
201,782
-11,718
-5% -$342K 0.17% 108
2024
Q2 		$5.97M Sell
213,500
-11,525
-5% -$317K 0.18% 104
2024
Q1 		$6.24M Buy
225,025
+36,424
+19% +$1.01M 0.2% 94
2023
Q4 		$5.43M Buy
188,601
+8,457
+5% +$256K 0.19% 96
2023
Q3 		$5.98M Sell
180,144
-4,734
-3% -$167K 0.3% 64
2023
Q2 		$6.78M Buy
184,878
+8,424
+5% +$328K 0.33% 60
2023
Q1 		$7.2M Sell
176,454
-4,323
-2% -$187K 0.44% 43
2022
Q4 		$9.26M Buy
180,777
+16,184
+10% +$776K 0.66% 21
2022
Q3 		$7.2M Buy
164,593
+248
+0.2% +$12.1K 0.59% 27
2022
Q2 		$8.62M Buy
164,345
+4,139
+3% +$211K 0.72% 21
2022
Q1 		$8.29M Sell
160,206
-9,970
-6% -$517K 0.59% 26
2021
Q4 		$10M Buy
170,176
+66,309
+64% +$3.29M 0.75% 19
2021
Q3 		$4.47M Buy
103,867
+59,397
+134% +$2.63M 0.61% 33
2021
Q2 		$1.74M Sell
44,470
-3,671
-8% -$143K 0.31% 56
2021
Q1 		$1.74M Buy
48,141
+39,538
+460% +$1.4M 0.34% 58
2020
Q4 		$317K Sell
8,603
-12,087
-58% -$443K 0.09% 154
2020
Q3 		$720K Buy
20,690
+7,567
+58% +$265K 0.32% 73
2020
Q2 		$407K Buy
+13,123
New +$446K 0.22% 61
2020
Q1 		– Sell
-5,648
Closed -$211K – 76
2019
Q4 		$211K Buy
+5,648
New +$201K 0.19% 68
2019
Q3 		– Sell
-1,241
Closed -$51K – 95
2019
Q2 		$51K Buy
+1,241
New +$49.3K 0.06% 96

Other funds holding PFE

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Apollon Wealth Management's PFE Position: Q3 2026 in Review

Apollon Wealth Management increased its Pfizer (PFE) stake by 11% in Q3 2026, buying an estimated $486K and bringing the position to 187,096 shares worth $5.34M. The position accounts for 0.06% of the portfolio, ranked #255.

Apollon Wealth Management first reported a position in PFE in Q2 2019 and has held it in 28 quarters since. The position peaked at $10M in Q4 2021. 1,998 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Apollon Wealth Management held 187,096 shares of Pfizer worth $5.34M as of Q3 2026.
  • Apollon Wealth Management bought 18,262 Pfizer shares in Q3 2026, an estimated $486K.
  • Pfizer made up 0.06% of Apollon Wealth Management's portfolio in Q3 2026, its #255 holding.
  • Apollon Wealth Management first reported a position in Pfizer in Q2 2019 and has held it in 28 quarters since.
  • Apollon Wealth Management's Pfizer position peaked at $10M in Q4 2021.
  • 1,998 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Apollon Wealth Management's 13F filing for Q3 2026, filed 23 Oct 2026.